Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$66,411,252
+$12,129,426 QoQ
Shares Held
525,655
+35.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#182
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. GILD ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
357,284 | $428,537,182 | |
| 2 | JNJ |
Johnson & Johnson
|
1,192,228 | $302,790,144 | |
| 3 | ABBV |
AbbVie Inc.
|
680,811 | $171,319,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,305,364 | $167,739,274 | |
| 5 | PFE |
Pfizer Inc
|
6,943,719 | $167,204,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,414,008 | $81,475,140 | |
| 7 | AMGN |
Amgen Inc
|
209,837 | $75,986,174 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
525,655 | $66,411,252 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,411,252 | 525,655 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $54,281,826 | 389,480 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $45,581,953 | 371,370 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $63,189,081 | 569,271 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $59,588,632 | 537,464 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $62,622,391 | 558,879 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $49,836,016 | 539,526 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $42,134,042 | 502,553 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $29,810,015 | 434,485 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $33,444,558 | 456,581 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $36,873,969 | 455,178 | Shares | Defined | 2025-12-09 | |
| 2023-09-30 | $38,989,332 | 520,274 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $38,567,060 | 500,416 | Shares | Defined | 2025-12-09 | |
| 2023-03-31 | $42,762,488 | 515,397 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $32,558,955 | 379,254 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $25,894,007 | 419,744 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $28,632,740 | 463,238 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $24,728,465 | 415,954 | Shares | Sole | 2025-12-09 | |
| 2021-12-31 | $29,421,789 | 405,203 | Shares | Sole | 2025-12-29 | |
| 2021-09-30 | $17,624,132 | 252,314 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $15,815,581 | 297,370 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $19,513,606 | 301,928 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $17,176,387 | 294,823 | Shares | Defined | 2025-12-29 | |
| 2020-09-30 | $3,819,582 | 60,446 | Shares | Defined | 2025-12-29 | |
| 2020-06-30 | $11,735,196 | 152,524 | Shares | Sole | 2025-12-29 | |
| 2020-03-31 | $6,678,011 | 89,326 | Shares | Defined | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||